🔎 Trials Near Me

Domov › Prekomerna telesna teža › Florida › Miami

Klinične študije za Prekomerna telesna teža v Miami, FL

23 študij za Prekomerna telesna teža išče udeležence na lokacijah v Miami in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Vključevanje udeležencevFaza 1
  • Clinical Pharmacology of Miami, Miami
Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Vključevanje udeležencevFaza 3
  • PharmaDev Clinical Research Institute LLC, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Vključevanje udeležencevFaza 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Age Medical Research Corporation, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Vključevanje udeležencevFaza 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

Vključevanje udeležencevFaza 1
  • Clinical Pharmacology of Miami, Miami
Starost 18–70 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07803744

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Horizon Research Center, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3
  • New Horizon Research Center, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Flourish Research - Miami, LLC, Miami
  • PharmaDev Clinical Research Institute, LLC, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Finlay Medical Research, Miami
  • Suncoast Research Group LLC, Miami
  • New Horizon Research Center, Miami
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • BioMed Research & Medical Center, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • New Horizon Research Center, Miami
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3
  • PharmaDev Clinical Research Institute LLC, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
  • ACCOMPLISH-2 Research Site, Miami
Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • New Horizon Research Center, Miami
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Vključevanje udeležencevFaza 3
  • Kailera Clinical Site, Miami
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • Optimus U Corporation, Miami
  • Research Institute of South Florida, Miami
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Vključevanje udeležencevFaza 3
  • Optimus U Corporation, Miami
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Vključevanje udeležencevFaza 3
  • New Horizon Research Center, Miami
  • Research Institute of South Florida, Miami
Starost 18–99 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Vključevanje udeležencevFaza 3
  • ACCOMPLISH-1 Research Site, Miami
Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Starost 12–17 · Vsi spoli · Posodobljeno 10. sep. 2025 · NCT06596265

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Starost 6–14 · Vsi spoli · Posodobljeno 4. sep. 2025 · NCT06595251

Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Starost 50–95 · Vsi spoli · Posodobljeno 4. sep. 2025 · NCT06604650

Študije za Prekomerna telesna teža v drugih mestih

Druge študije v Miami

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.